NCT01767103View on ClinicalTrials.gov

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Hepatic Impairment
Interventions
DRUG

Ferriprox®

Trial Locations (2)

32809

Orlando Clinical Research Center, Orlando

33136

University of Miami, Miami

Sponsors

Lead Sponsor

ApoPharma
All Listed Sponsors
lead

ApoPharma

INDUSTRY

NCT01767103 - An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers | Biotech Hunter | Biotech Hunter